Onderzoeker
Katrijn Broos
- Trefwoorden:Geneeskunde
- Disciplines:Natuurwetenschappen, Algemene en logistieke diensten, Sociale wetenschappen
Affiliaties
- Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf8 apr 2019 → 6 okt 2019 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf7 aug 2015 → 11 okt 2019 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 6 okt 2019 - Laboratorium voor Moleculaire en Cellulaire Therapie (Onderzoeksgroep)
Lid
Vanaf1 sep 2013 → 19 mrt 2021 - Fysiologie (Departement)
Lid
Vanaf1 sep 2013 → 31 dec 2013
Publicaties
1 - 10 van 13
- Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine(2023)
Auteurs: T Ertveldt, Sofie Meulewaeter, Y De Vlaeminck, Oscar Olarte, Katrijn Broos, Serge Van Calenbergh, Stephanie Bourgeois, Joke Deprez, Yves Heremans, Cleo Goyvaerts, et al.
Pagina's: 5483-5500 - Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells(2022)
Auteurs: Philipp Kalus, Jolien De Munck, Sarah Vanbellingen, Laura Carreer, Thessa Laeremans, Katrijn Broos, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Bart Neyns, et al.
- Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Auteurs: R M Awad, Q Lecocq, Katty Zeven, T Ertveldt, L De Beck, Hannelore Ceuppens, Katrijn Broos, Y De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
Pagina's: 172-182 - Anti-human PD-L1 Nanobody for Immuno-PET Imaging(2020)
Auteurs: Jessica Bridoux, Katrijn Broos, Q Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, G Raes, Sara Neyt, , K Breckpot, et al.
Pagina's: 1-15 - Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production(2019)
Auteurs: Katrijn Broos, Q Lecocq, Brenda De Keersmaecker, G Raes, Jurgen Corthals, Eva Lion, Kris Thielemans, Nick Devoogdt, M Keyaerts, K Breckpot
Pagina's: E85-E85 - Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent(2019)
Auteurs: Katrijn Broos, Q Lecocq, Catarina Xavier, Jessica Bridoux, Tham Nguyen, Jurgen Corthals, Steve Joël Marie-José Schoonooghe, Eva Lion, G Raes, M Keyaerts, et al.
- Evaluating single domain antibodies specific for PD-L1 as cancer nuclear imaging and therapy agents(2019)
Auteurs: Katrijn Broos, K Breckpot
- A versatile T cell-based assay to assess therapeutic antigenspecific PD-1-targeted approaches(2018)
Auteurs: Maarten Versteven, Johan M.J. Van den Bergh, Katrijn Broos, Fumihiro Fujiki, Diana Campillo-Davo, Hans De Reu, Soyoko Morimoto, Q Lecocq, M Keyaerts, Zwi Berneman, et al.
Pagina's: 27797-27808 - Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy(2018)
Auteurs: Katrijn Broos, Q Lecocq, G Raes, Nick Devoogdt, M Keyaerts, K Breckpot
Pagina's: 3559-3570 - Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers(2017)
Auteurs: Katrijn Broos, M Keyaerts, Q Lecocq, Dries Renmans, Nguyen T., D. Escors, Liston A., G Raes, K Breckpot, Nick Devoogdt
Pagina's: 41932-41946